Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-264019

Options or other derivatives

  • Director acquired 35,152 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Incerti Carlo Director 2026-06-05 Grant or award · Stock option (right to buy) +35,152 35,152 D
Loading xslF345X06/ownership.xml…